[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622555":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":23,"centralContacts":24,"locations":30,"responsibleParty":50,"collaborators":52,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":23,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":23,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":33,"whyStopped":23,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"SF Research Institute, Inc.","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Dietary Supplement Group","EXPERIMENTAL","Participants in this arm will receive the investigational dietary supplement (Kids Multi \\& Omegas) in gummy form. Subjects will be instructed to take two gummies once daily, with or without food, for a total duration of 4 weeks. Blood samples will be collected at baseline and at the end of the study to evaluate changes in selected serum nutritional biomarkers.",[13],"Dietary Supplement: Dietary Supplement (Kids Multi & Omegas)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIETARY_SUPPLEMENT","Dietary Supplement (Kids Multi & Omegas)","The intervention consists of a gummy dietary supplement administered orally to healthy children. Participants will be instructed to take two gummies once daily, with or without food, starting on Day 1 and continuing for a total duration of 4 weeks. The supplement contains vitamins, minerals, and omega-3 fatty acids, including vitamin D, vitamin B12, folate, and polyunsaturated fatty acids (DHA and EPA). The intervention is evaluated by measuring serum nutritional biomarkers at baseline and after 4 weeks of supplementation.",[9],[21,22],"SPV20251119 - 01","Product A",null,[25],{"name":26,"role":27,"phone":28,"phoneExt":23,"email":29},"Dr. John Ademola","CONTACT","415-845-4638","jademola@sfinstitute.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"San Francisco Research Institute","RECRUITING","San Francisco","California","94132","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-122.41942,37.77493,{"lat":43,"lon":42},[46],{"name":47,"role":27,"phone":48,"phoneExt":23,"email":49},"Khaleeq Rehman","415-690-9641","khaleeqr.sfinstitute@gmail.com",{"type":51,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR",[53],{"name":54,"class":55},"Smarty Pants Vitamins","UNKNOWN","100622555","a-study-of-a-dietary-supplement-on-serum-biomarkers-in-children-100622555",false,"NCT07385144","A Study of a Dietary Supplement on Serum Biomarkers in Children","A Pilot Study Evaluating the Effects of a Dietary Supplement on Serum Biomarkers in Children","Inclusion Criteria:\n\n* Healthy Male and Females aged 4 - 15 years\n* NORMAL BMI \u002Fgrowth (per CDC growth tables) Between 5th - 85th percentile.\n* Able to read, understand, and complete the study questionnaire and records.\n* Able to understand the study procedures.\n* Able to comply with all study requirements.\n* Written informed consent\u002FAssent to participate in the study.\n* Agrees to maintain current lifestyle habits (diet, physical activity, medications, and sleep) as much as possible throughout the study and avoid taking new supplements\n* Willingness to actively participate in the study and to come to the scheduled visits.\n\nExclusion Criteria:\n\n* Immune insufficiency\n* Use of systemic corticosteroids or immunosuppressant drugs.\n* Any diseases or medications that might directly interfere in the study or put the subject's health under risk.\n* Currently taking any prescription medications or any dietary supplements including multivitamins\n* Employees of the institute or the brand owner or the manufacturers of the product\n* Cardiovascular-, chronic liver-, thyroid or kidney diseases; a history of cancer; a disease or condition that could influence the participants' ability to follow the study protocol,",true,"ALL","4 Years","15 Years",{"count":68,"type":69},30,"ESTIMATED","INTERVENTIONAL",[72],"NA","This is a pilot clinical study designed to evaluate the effects of a dietary supplement on selected blood-based nutritional biomarkers in healthy children aged 4 to 15 years.\n\nApproximately 24 children will be screened and enrolled to account for potential dropouts, with a target of 20 participants completing the study. Eligible participants will attend a screening and baseline visit, followed by daily intake of the study supplement for 4 weeks. After the supplementation period, participants will return to the clinic for an end-of-study visit.\n\nBlood samples will be collected at baseline and after 4 weeks to measure nutritional biomarkers, including vitamin D, vitamin B12, folate, omega-3 fatty acids, and standard blood count parameters. Additional assessments include height, weight, body mass index (BMI), and a socioeconomic questionnaire. Throughout the study, participants or their caregivers will record daily supplement intake, any medications taken, and any adverse events in a study diary.\n\nThe results of this pilot study will provide preliminary data on the effects of the dietary supplement on serum biomarkers in children.",[75,76],"Nutritional Status","Serum Biomarkers",[78,79,80,81,82,83,84],"Dietary Supplement","Pediatric Nutrition","Nutritional Biomarkers","Vitamins","Omega-3 Fatty Acids","Vitamin D","Vitamin B12","2026-02-02",{"date":87,"type":88},"2026-02-04","ACTUAL",{"date":90,"type":69},"2026-01-30",{"date":92,"type":69},"2026-03-05",{"name":5,"class":6},1]